Abstract:3013 Triplex-forming oligonucleotides (TFOs) are single-stranded oligonucleotides that can inhibit gene transcription by binding to specific gene sequences. Our goal is to investigate the potential of gene-specific TFOs to inhibit oncogene expression and cell proliferation. To date, gene specific TFOs have been shown to be able to regulate the expression of ∼10 human oncogenes in cells, including BCR/ABL, MYC, EGFR, ERBB2, IGFI, SIS, FOS, Ha-RAS, c-Ki-RAS and SRC. In order to expand our study to other human genes and to mouse models, we identified 27 new triplex-forming sites with high TFO binding affinity and specificity in 17 mouse genes (Egfr, Erbb2, Igf1r, Tgfa, Tnf, Tnfr1, Src, Akt1, Stat1, Stat3, Stat5, Ccnd1, Odc1, Cox2, Icam1, Vegfa, and Nfkbia) and 2 human genes (ODC and COX2). Here we present one example targeting the Stat3 gene with a Stat3-specific TFO in mice. Signal transducers and activators of transcription (STATs) are a family of latent cytoplasmic proteins involved in transmitting extracellular signals to the nucleus. Constitutive activation of Stats, in particular STAT3, is found in a number of primary human epithelial tumors and cancer cell lines, including squamous cell carcinomas of the head and neck, breast, ovary, prostate, and lung. STAT3 participates in cell proliferation through regulation of several genes such as CCND1 and MYC. K14.TGFa mice, which exhibit dramatic and persistent epidermal hyperproliferation, provide a useful mouse model to evaluate the efficacy of TFOs as a gene targeting approach to control epidermal hyperproliferation. A 27-mer TFO, which binds to its target sequence in the Stat3 gene with high affinity and specificity, was injected intradermally into the epidermis of K14.TGFa mice. The transcription level of the Stat3 gene was decreased to ∼45% of that in vehicle-treated control mouse skin, as assessed by real-time PCR. Treatment with the Stat3-specific TFO also resulted in reduction of the transcription levels of the Ccnd1 and Myc genes, which are downstream targets of Stat3. Thus, our findings demonstrate that triplex-induced transcription inhibition of Stat3 can be accomplished in intact animals following intradermal injection.

STAT3-decoy Oligodeoxynucleotide Inhibits the Growth of Human Lung Cancer Via Down-Regulating Its Target Genes

Therapeutic Effects of Stat3 Decoy Oligodeoxynucleotide on Human Lung Cancer in Xenograft Mice

Growth Inhibition of Human Hepatocellular Carcinoma Cells by Blocking STAT3 Activation with Decoy-Odn.

Physalin A Exerts Anti-Tumor Activity in Non-Small Cell Lung Cancer Cell Lines by Suppressing JAK/STAT3 Signaling.

Identification of ATAD3A As a Key Regulator in Non-Small Cell Lung Cancer by Promoting STAT3-induced Cell Proliferation and Tumor Angiogenesis

Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

Down-Regulation Of Signal Transducer And Activator Of Transcription 3 Expression Using Vector-Based Small Interfering Rnas Suppresses Growth Of Human Prostate Tumor In Vivo

Small-molecule Compounds Targeting the STAT3 DNA-binding Domain Suppress Survival of Cisplatin-Resistant Human Ovarian Cancer Cells by Inducing Apoptosis.

An experimental study on decoy oligodeoxynucleotides targeting activated STAT3 to suppress bladder cancer cell growth

HJC0152, a Novel STAT3 Inhibitor with Promising Anti-Tumor Effect in Gastric Cancer

Deactivation of Signal Transducer and Activator of Transcription 3 Reverses Chemotherapeutics Resistance of Leukemia Cells Via Down-Regulating P-Gp

A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in

Effects on the STAT3-shRNA in Non-Small-Cell Lung Cancer Therapy: Design, Induction of Apoptosis, and Conjugation with Chitosan-Based Gene Vectors

A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion

A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells

The Antiproliferative and Colony-suppressive Activities of STAT3 Inhibitors in Human Cancer Cells Is Compromised Under Hypoxic Conditions.

Inhibiting the Otub1/phosphorylated STAT3 axis for the treatment of non-small cell lung cancer

Regulation of Stat3 Gene Transcription by Triplex-Forming Oliogonucleotides in Mice

Upregulation of Id 3 Inhibits Cell Proliferation and Induces Apoptosis in A 549 / DDP Human Lung Cancer Cells in Vitro

Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells.